A

Acrivon Therapeutics Inc
NASDAQ:ACRV

Watchlist Manager
Acrivon Therapeutics Inc
NASDAQ:ACRV
Watchlist
Price: 2.95 USD -1.99% Market Closed
Market Cap: 93.1m USD

Wall Street
Price Targets

ACRV Price Targets Summary
Acrivon Therapeutics Inc

Wall Street analysts forecast ACRV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACRV is 11.39 USD with a low forecast of 6.06 USD and a high forecast of 19.95 USD.

Lowest
Price Target
6.06 USD
105% Upside
Average
Price Target
11.39 USD
286% Upside
Highest
Price Target
19.95 USD
576% Upside
Acrivon Therapeutics Inc Competitors:
Price Targets
UTHR
United Therapeutics Corp
3% Upside
TGTX
TG Therapeutics Inc
49% Upside
VCYT
Veracyte Inc
9% Upside
ASMB
Assembly Biosciences Inc
55% Upside
BMEA
Biomea Fusion Inc
437% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
47% Upside
ALT
Altimmune Inc
349% Upside
URGN
Urogen Pharma Ltd
55% Upside

Revenue
Forecast

Revenue Estimate
Acrivon Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Acrivon Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Acrivon Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-29%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACRV's stock price target?
Price Target
11.39 USD

According to Wall Street analysts, the average 1-year price target for ACRV is 11.39 USD with a low forecast of 6.06 USD and a high forecast of 19.95 USD.

Back to Top